Intech Investment Management LLC Has $5.35 Million Stock Position in Maximus, Inc. $MMS

Intech Investment Management LLC grew its position in shares of Maximus, Inc. (NYSE:MMS) by 18.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 61,956 shares of the health services provider’s stock after acquiring an additional 9,720 shares during the quarter. Intech Investment Management LLC’s holdings in Maximus were worth $5,348,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its stake in shares of Maximus by 19.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock worth $18,304,000 after purchasing an additional 33,136 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after buying an additional 36,989 shares during the last quarter. Divisadero Street Capital Management LP boosted its holdings in shares of Maximus by 93.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock valued at $16,800,000 after buying an additional 88,872 shares during the last quarter. WINTON GROUP Ltd acquired a new stake in shares of Maximus in the 3rd quarter valued at approximately $6,208,000. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Maximus in the 4th quarter valued at approximately $15,673,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 742 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares in the company, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.80% of the company’s stock.

Maximus Trading Up 0.1%

NYSE MMS opened at $62.01 on Monday. The company has a market cap of $3.26 billion, a PE ratio of 9.28 and a beta of 0.58. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 12 month low of $56.92 and a 12 month high of $100.00. The stock has a 50 day moving average of $64.51 and a 200-day moving average of $77.29.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the business earned $2.01 EPS. The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Friday, May 15th. Maximus’s dividend payout ratio is 19.76%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.